Vitrolife´s CEO has purchased shares

Rhea-AI Summary

On October 28, 2022, Thomas Axelsson, CEO of Vitrolife, acquired 12,000 shares valued at 2,124,000 MSEK, increasing his total holdings to 25,000 shares. This transaction adheres to regulatory requirements and will be reported to the Swedish Financial Supervisory Authority. The information is disclosed under the EU Market Abuse Regulation and the Securities Markets Act, ensuring compliance and transparency regarding executive stock purchases.

Positive

• CEO Thomas Axelsson's personal investment of 2,124,000 MSEK indicates confidence in Vitrolife's future performance.
• Increase in total shares held by the CEO to 25,000 demonstrates strong commitment.

Negative

• None.

News Market Reaction – VTRLY

%

1 alert

% News Effect

On the day this news was published, VTRLY declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GOTHENBURG, Sweden, Oct. 28, 2022 /PRNewswire/ -- Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 MSEK. The total holdings of shares amount to 25,000.

The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.

Gothenburg, October 28, 2022
VITROLIFE AB (publ)
Thomas Axelsson, CEO

CONTACT:

Contact persons:
Thomas Axelsson,
CEO,
phone: +46 31 721 80 01
Patrik Tolf,
CFO,
phone: +46 31 766 90 21

This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 10.45 am CET on October 28, 2022.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

The following files are available for download:

https://mb.cision.com/Main/1031/3657455/1645398.pdf

Vitrolife´s CEO has purchased shares

 

View original content:https://www.prnewswire.com/news-releases/vitrolifes-ceo-has-purchased-shares-301662183.html

SOURCE Vitrolife AB (publ)

FAQ

What recent stock transaction did Vitrolife's CEO Thomas Axelsson make?

On October 28, 2022, Thomas Axelsson acquired 12,000 shares of Vitrolife worth 2,124,000 MSEK.

How many shares does Thomas Axelsson own after his recent purchase?

After the purchase, Thomas Axelsson holds a total of 25,000 shares of Vitrolife.

Is the recent share purchase by Vitrolife's CEO reported to any authority?

Yes, the transaction will be reported to the Swedish Financial Supervisory Authority.

What is the significance of CEO share purchases in a company?

CEO share purchases often signal confidence in the company's future and can positively influence investor sentiment.